Literature DB >> 22531611

The relationship between cerebral vascular disease and parkinsonism: The VADO study.

A Antonini1, C Vitale, P Barone, R Cilia, A Righini, U Bonuccelli, G Abbruzzese, S Ramat, A Petrone, R Quatrale, R Marconi, R Ceravolo, A Stefani, L Lopiano, M Zappia, L Capus, L Morgante, F Tamma, M Tinazzi, C Colosimo, U P Guerra.   

Abstract

BACKGROUND: The observation of gait abnormalities, parkinsonism and vascular lesions in elderly patients is often reported as vascular parkinsonism (VP). However the status of striatal dopamine transporter (DAT) and the effects of brain vascular lesions on motor features and levodopa responsiveness are poorly defined.
METHODS: We recorded clinical features, chronic response to levodopa and vascular risk factors in a cross-sectional cohort of consecutive elderly patients with possible Parkinson's disease (PD) or VP recruited in 20 centers in Italy.
RESULTS: We included a total of 158 patients. Onset of motor symptoms was asymmetric in 93 (59%) and symmetric in 65 patients (41%). Symmetric motor onset was associated with greater disease severity. Chronic levodopa response was positive in 75 (47.8%) and negative in 82 patients (52.2%). A negative response to levodopa was associated with greater frequency of symmetric onset of motor symptoms, worst disease severity, absence of dyskinesia and greater number of vascular risk factors. Frontal lobe showed largest vascular load. Striatal DAT was normal in 48 (30.4%) and abnormal in 110 (69.6%) patients. Patients with normal DAT binding showed higher vascular load at MRI. Significant predictive factors of worst disease severity and negative response to levodopa were hypertension, vascular lesions in basal ganglia/periventricular regions, and normal DAT uptake.
CONCLUSIONS: Multiple cerebral vascular lesions modify clinical presentation and severity in patients with parkinsonism and this is underlined by specific risk factors primarily hypertension. Striatal DAT assessment is helpful in identifying patients where therapy benefit is less likely.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22531611     DOI: 10.1016/j.parkreldis.2012.03.017

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  22 in total

Review 1.  The contribution of white matter lesions to Parkinson's disease motor and gait symptoms: a critical review of the literature.

Authors:  Branislav Veselý; Angelo Antonini; Ivan Rektor
Journal:  J Neural Transm (Vienna)       Date:  2015-10-19       Impact factor: 3.575

Review 2.  An updated diagnostic approach to subtype definition of vascular parkinsonism - Recommendations from an expert working group.

Authors:  Ivan Rektor; Nicolaas I Bohnen; Amos D Korczyn; Viktoria Gryb; Hrishikesh Kumar; Milica G Kramberger; Frank-Erik de Leeuw; Zvezdan Pirtošek; Irena Rektorová; Ilana Schlesinger; Jaroslaw Slawek; Peter Valkovič; Branislav Veselý
Journal:  Parkinsonism Relat Disord       Date:  2017-12-29       Impact factor: 4.891

3.  Levels of HVA, 5-HIAA, and MHPG in the CSF of vascular parkinsonism compared to Parkinson's disease and controls.

Authors:  Megan K Herbert; H Bea Kuiperij; Bastiaan R Bloem; Marcel M Verbeek
Journal:  J Neurol       Date:  2013-12       Impact factor: 4.849

4.  Machine learning models for the differential diagnosis of vascular parkinsonism and Parkinson's disease using [(123)I]FP-CIT SPECT.

Authors:  I Huertas-Fernández; F J García-Gómez; D García-Solís; S Benítez-Rivero; V A Marín-Oyaga; S Jesús; M T Cáceres-Redondo; J A Lojo; J F Martín-Rodríguez; F Carrillo; P Mir
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-14       Impact factor: 9.236

5.  The MTHFR C677T polymorphism modifies age at onset in Parkinson's disease.

Authors:  Annamaria Vallelunga; Valentina Pegoraro; Manuela Pilleri; Roberta Biundo; Angela De Iuliis; Mauro Marchetti; Silvia Facchini; Patrizia Formento Dojot; Angelo Antonini
Journal:  Neurol Sci       Date:  2013-09-20       Impact factor: 3.307

Review 6.  Vascular parkinsonism--characteristics, pathogenesis and treatment.

Authors:  Amos D Korczyn
Journal:  Nat Rev Neurol       Date:  2015-04-28       Impact factor: 42.937

7.  Impact of subcortical white matter lesions on dopamine transporter SPECT.

Authors:  Elisabeth Funke; Andreas Kupsch; Ralph Buchert; Winfried Brenner; Michail Plotkin
Journal:  J Neural Transm (Vienna)       Date:  2013-01-24       Impact factor: 3.575

8.  Reversible parkinsonism due to a large intracranial tumour.

Authors:  Helena Rocha; António Cerejo; Maria Carolina Garrett; João Massano
Journal:  BMJ Case Rep       Date:  2012-12-23

9.  Cognitive and MRI correlates of orthostatic hypotension in Parkinson's disease.

Authors:  Manuela Pilleri; Silvia Facchini; Elisabetta Gasparoli; Roberta Biundo; Laura Bernardi; Mauro Marchetti; Patrizia Formento; Angelo Antonini
Journal:  J Neurol       Date:  2012-08-01       Impact factor: 4.849

Review 10.  Neuroimaging in Parkinson disease: from research setting to clinical practice.

Authors:  Marios Politis
Journal:  Nat Rev Neurol       Date:  2014-11-11       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.